EP1487427A4 - Procedes de prevention et de traitement de la neuropathie peripherique par administration de desmethylselegiline - Google Patents

Procedes de prevention et de traitement de la neuropathie peripherique par administration de desmethylselegiline

Info

Publication number
EP1487427A4
EP1487427A4 EP03716304A EP03716304A EP1487427A4 EP 1487427 A4 EP1487427 A4 EP 1487427A4 EP 03716304 A EP03716304 A EP 03716304A EP 03716304 A EP03716304 A EP 03716304A EP 1487427 A4 EP1487427 A4 EP 1487427A4
Authority
EP
European Patent Office
Prior art keywords
desmethylselegiline
administering
preventing
methods
peripheral neuropathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03716304A
Other languages
German (de)
English (en)
Other versions
EP1487427A1 (fr
Inventor
Cheryl D Blume
Anthony R Disanto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somerset Pharmaceuticals Inc
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of EP1487427A1 publication Critical patent/EP1487427A1/fr
Publication of EP1487427A4 publication Critical patent/EP1487427A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03716304A 2002-03-04 2003-03-04 Procedes de prevention et de traitement de la neuropathie peripherique par administration de desmethylselegiline Withdrawn EP1487427A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36160902P 2002-03-04 2002-03-04
US361609P 2002-03-04
PCT/US2003/006690 WO2003075906A1 (fr) 2002-03-04 2003-03-04 Procedes de prevention et de traitement de la neuropathie peripherique par administration de desmethylselegiline

Publications (2)

Publication Number Publication Date
EP1487427A1 EP1487427A1 (fr) 2004-12-22
EP1487427A4 true EP1487427A4 (fr) 2006-01-18

Family

ID=27805055

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03716304A Withdrawn EP1487427A4 (fr) 2002-03-04 2003-03-04 Procedes de prevention et de traitement de la neuropathie peripherique par administration de desmethylselegiline

Country Status (7)

Country Link
EP (1) EP1487427A4 (fr)
JP (1) JP2005525377A (fr)
CN (2) CN100506220C (fr)
CA (1) CA2478026A1 (fr)
HK (1) HK1080716A1 (fr)
MX (1) MXPA04008574A (fr)
WO (1) WO2003075906A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005269416B2 (en) * 2004-07-26 2011-07-28 Teva Pharmaceutical Industries, Ltd. Pharmaceutical dosage forms including rasagiline
US20110124606A1 (en) * 2007-11-19 2011-05-26 Snow Brand Milk Products Co., Ltd. Sense-improving agent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022068A2 (fr) * 1995-01-13 1996-07-25 Somerset Pharmaceuticals, Inc. Procedes et compositions pharmaceutiques utilisant de la desmethylselegiline
WO1997033572A1 (fr) * 1996-03-15 1997-09-18 Somerset Pharmaceuticals, Inc. Methode de prevention et de traitement de la neuropathie peripherique par administration de selegiline
WO1999018946A1 (fr) * 1997-10-14 1999-04-22 Tatton Nadine A Techniques permettant d'accroitre la survie des cellules de schwann

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2029805T3 (es) * 1986-04-16 1992-10-01 Asta Pharma Aktiengesellschaft Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022068A2 (fr) * 1995-01-13 1996-07-25 Somerset Pharmaceuticals, Inc. Procedes et compositions pharmaceutiques utilisant de la desmethylselegiline
WO1997033572A1 (fr) * 1996-03-15 1997-09-18 Somerset Pharmaceuticals, Inc. Methode de prevention et de traitement de la neuropathie peripherique par administration de selegiline
WO1999018946A1 (fr) * 1997-10-14 1999-04-22 Tatton Nadine A Techniques permettant d'accroitre la survie des cellules de schwann

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03075906A1 *

Also Published As

Publication number Publication date
MXPA04008574A (es) 2005-07-13
CN100506220C (zh) 2009-07-01
CN1891213A (zh) 2007-01-10
WO2003075906A1 (fr) 2003-09-18
CA2478026A1 (fr) 2003-09-18
EP1487427A1 (fr) 2004-12-22
AU2003220016A1 (en) 2003-09-22
JP2005525377A (ja) 2005-08-25
CN1646109A (zh) 2005-07-27
HK1080716A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
ZA200503967B (en) Agent for preventing or treating neuropathy
IL233205B (en) Substances for the treatment or prevention of pre-eclampsia
EP1484366A4 (fr) Pigment traite, utilisation associee et compose de traitement de pigments
EP1565644A4 (fr) Procede et systeme de traitement d'un trou de forage
MY143799A (en) Compositions and methods for treating diabetes
IL169633A0 (en) Combination therapy for treating protein deficiencies
AU2002325435A8 (en) Medication and method for treating pathological syndrome
IL164219A0 (en) Method for treating and preventing hyparathyroidism
EP1468118A4 (fr) Procedes et compositions pour le traitement du cancer
EP1572118A4 (fr) Methodes et compositions de traitement de cancer au moyen des genes 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883
EP1567198A4 (fr) Procedes et materiaux destines a traiter des troubles oculaires
HUS1300035I1 (hu) Dihidroimidazolonok alkalmazása epilepszia kezelésére kutyákban
GB2425617B (en) Device for preventing and treating myopia
AU2003232044A8 (en) Composition and method for dermatological treatment
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
AU2003256526A8 (en) Arrangements and methods for treating a subject
GB0201498D0 (en) Materials and methods for treating cancer
EP1558238A4 (fr) Beta-hydroxyphenylaldylamines et utilisation de celles-ci pour traiter le glaucome
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
EP1575993A4 (fr) Methodes de traitement de patients et d'identification de therapeutique
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
EP1545554A4 (fr) Methodes et compositions permettant de traiter les diabetes sucres
IL166062A0 (en) Compositions and methods for therapeutic treatment
EP1487427A4 (fr) Procedes de prevention et de traitement de la neuropathie peripherique par administration de desmethylselegiline
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040913

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DISANTO, ANTHONY R.ARD PHARMACEUT. CONSULTING INC

Inventor name: BLUME, CHERYL, D.

A4 Supplementary search report drawn up and despatched

Effective date: 20051202

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/02 20000101ALI20051128BHEP

Ipc: A61K 31/137 20000101AFI20051128BHEP

17Q First examination report despatched

Effective date: 20071127

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080408